English
Regional settings| Spread | 0.11 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ £5,000.00 Short position overnight fee ~ £4,000.00 | -0.025295% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ £5,000.00 Short position overnight fee ~ £4,000.00 | 0.003377% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | GBP | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||
| Commission on trade1 | 0% |
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 22.35 |
| Open | 22.09 |
| 1-Year Change | -4.46% |
| Day's Range | 22.03 - 22.33 |
Halma plc is a United Kingdom-based life-saving technology company. The Company operates through four segments: Process Safety, Infrastructure Safety, Environmental & Analysis and Medical. The Process Safety segment offers products, such as specialized interlocks that control critical processes safely; instruments that detect flammable and hazardous gases; and explosion protection and corrosion monitoring systems. The Infrastructure Safety segment offers products, such as fire detection systems, specialist fire suppression systems, elevator safety systems and people and vehicle flow technologies. The Environmental & Analysis segment offers products, such as opto-electronic technology and sensors, flow gap measurement instruments and gas conditioning products, and solutions for environmental data recording, water quality testing and ultraviolet (UV) water treatment. The Medical segment offers products, such as critical fluidic components, laboratory devices and systems.
BRIEF: For the six months ended 30 September 2021, Halma plc revenues increased 19% to £737.2M. Net income increased 76% to £135.8M. Revenues reflect Process Safety segment increase of 19% to £320.2M, Medical segment increase of 21% to £208M, Environmental & Analysis segment increase of 18% to £209.5M, United Kingdom segment increase of 55% to £136.2M, United States of America segment increase of 10% to £280.9M.
